Antibodies
6 April 2011
Circadian’s VGX-100 Inhibits Tumour Growth in Models of Lung, Ovarian and Prostate Cancer6 April 2011
Circadian’s Partner ImClone Systems Commences First Phase 1 Clinical Trial of VEGFR-3 Antibody IMC-3C56 April 2011
Immunomedics Presents New DNL-Derived Antibodies for Mantle Cell Lymphoma at AACR Annual Meeting6 April 2011
Immunomedics Announces Preclinical Results of TF2 for Pretargeted Imaging of Colon Cancer5 April 2011
ImmunoGen, Inc. Announces First Data for Its IMGN529 Product Candidate for Non-Hodgkin’s Lymphoma5 April 2011
Immunomedics Reports Progress on Development of Antibody-SN-38 Conjugates at Cancer Meeting5 April 2011
Celldex to Present Data for Novel Immunotherapy Antibody Program at 102nd Annual AACR Meeting5 April 2011
BiTE Antibody MT112/BAY 2010112 Demonstrates Potent Activity against Human Prostate Cancer Cells4 April 2011
ImmunoGen, Inc. Announces First Data for its Novel Therapeutic for Ovarian Cancer and Other Carcinomas30 March 2011
Erbitux Indication Extension Submitted for 1st-Line Advanced or Metastatic NSCLC in the EU28 March 2011
Ablynx Initiates Phase I/II Trial for Alx-0061 (Anti-Il-6R) in Patients With Rheumatoid Arthritis23 March 2011
KaloBios Initiates Phase 1 Clinical Trial of KB004 in EphA3-Expressing Hematologic MalignanciesNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports